Aureus Pharma releases AurSCOPE® Kinase Knowledge Database

Date Posted: Wednesday, August 09, 2006

Print Email to a friend

Aureus Pharma has released AurSCOPE® Kinase Knowledge database. This knowledge database has already been licensed by several life science companies.

AurSCOPE Kinase contains biological activity data mined from scientific journals and patents. It contains up to date data including all published chemical structure activity relationships concerning kinase-ligand interactions.

It is a complementary addition to the Aureus Pharma knowledge management product portfolio focusing on various target classes.

Aureus also offers drug target knowledgebases for G-Protein Coupled receptor (GPCR) and ion channels as well as pharmaceutical safety based knowledgebases for ADME/Drug-Drug Interactions and the hERG channel.

"The AurSCOPE Kinase Knowledgebase will be a valuable resource for the pharmaceutical industry," said Dr. André Michel, Aureus Pharma's CEO. "It offers researchers the functionality to improve and accelerate lead discovery and optimization tasks involved in the drug discovery process".

Further Information:

Request Information From Vendor

Related news from our archive

Aureus Strengthens Executive Management Team
Aureus appoints Jason Theodosiou as chief operating officer and also as member of the Aureus Board of Directors.

Aureus Pharma Licenses AurWEB to Origenis
AurWEB is designed to allow access to all of Aureus’ knowledge databases, which include AurSCOPE GPCR, Ion Channel, Kinase, ADME/Drug-Drug interactions and hERG.

Aureus licenses AurSCOPE Ion Channel Knowledgebase to Xention
Access to this knowledge database will help Xention to use the selectivity profile and ADMET properties of existing drugs.

Aureus Licenses AurSCOPE ADME/DDI and hERG Knowledge Databases to Siena
Aureus’ ADME/DDI and hERG knowledge databases contain data which can help assess the safety of a potential pharmaceutical candidate.